Ha-ras and p53 gene mutations scanned by PCR-SSCP in human papillomavirus associated with premalignant and malignant lesions of the uterine cervix;Mutaciones en genes Ha-ras y p53 detectadas mediante PCR-SSCP en lesiones premalignas y malignas de cuello uterino asociadas con virus papiloma humano

Medicina

Volumn 60, Issue 6, 2000, Pages 895-901

  Alonio, Lidia Virginia ^a,d   Dalbert, Delia ^b   Picconi, Maria Alejandra ^a   Vazquez, Guadalupe Cervantes ^c   Carranca, Alejandro Garcia ^c   Distefano, Angelica L ^a   Mural, Juan ^b   Bartt, Ofelia ^b   Bazan, Graciela ^b   Teyssie, Angelica R ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^d NONE   (Argentina)

Author keywords

Ha ras; HPV; p53; Uterine cervical cancer

Indexed keywords

VIRUS DNA;

ARTICLE; FEMALE; GENETICS; HUMAN; MUTATION; ONCOGENE RAS; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

DNA, VIRAL; FEMALE; GENES, P53; GENES, RAS; HUMANS; MUTATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0034570837     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Schiffman MH. New epidemiology of human Papillomavirus infection and cervical neoplasia. J Nat Cancer Inst 1995; 87: 1345-7.
2. Syrjänen KJ. Human Papillomavirus in genital carcinogenesis. Transmitted Dis 1994; 21: 886-9.
3. International Agency for Research on Cancer, Lyon. Human Papillomaviruses. Vol 64 Monographs on the evaluation of carcinogenic risks to humans; 1995.
4. zur Hausen H, de Villier E. Human Papillomaviruses. Annu Rev Microbiol 1994; 48: 427-47.
5. Band D, Zajchowsky V, Kulesa R, Lager R. Human papillomavirus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA 1990; 87: 463-8.
6. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiological evidence showing that human Papillomavirus infection causes most cervical intraepithelial neoplasia. J Nat Cancer Inst 1993; 85: 958-64.
7. van den Brule AJ, Du Maine M, Kenemans P, Meijer CJLM, Walboomers JMM. Difference in prevalence of human Papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991; 48: 404-8.
8. Teyssié AR, Alonio LV, Distéfano AL, Picconi MA. Virología. En: El virus Papiloma en la pareja humana. Mural J, Teyssié A, Baitrochi C, Alfonsín A (eds). Buenos Aires: Editorial Ascune, 1993, p 25-45.
9. Jacobs M, de Roda Husman A, Van den Brule A, Snijders PJF, Meijer CJLM, Walboomers JMM. Group specific differentiation between high-and low-risk human Papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotides probes. J Clin Microbiol 1995; 33: 901-5.
10. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital HPV infection in low risk women in Portland, Oregon. Sex Transm Dis 1993; 20: 274-8.
11. Melki R, Khoury B, Catalan F. Nucleic acid spot hibridization with non radioactive labeled probes in screening for human Papillomavirus DNA sequences. J Med Virol 1988; 26: 137-43.
12. Alonio LV, Dalbert D, Mural J, et al. Different Papillomaviruses in uterine cervical lesions: detection and location by in situ hybridization with biotynilated probes. The Cervix & lfgt 1990; 3: 339-46.
13. Cox JT, Lörincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human Papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obst & Gynecol 1995; 172: 946-54.
14. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital Papillomaviruses. Cancer Cells 1989; 7: 209-14.
15. Evander M, Edlund K, Boden E. Comparison of a one step and a two-step polymerase chain reaction with degenerate general primers in a population based study of human Papillomavirus infection in youngs swedish women. J Clin Microbiol 1992; 30: 987-92.
16. Snijders PJF, van den Brule AJ, Schrijnemakers HJF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human Papillomavirus genotypes. J Gen Virol 1990; 71: 173-81.
17. Picconi MA, Eiján AM, Distéfano AL, et al. Human Papillomavirus (HPV) DNA in penile carcinomas in Argentina: an anlysis of primary tumors and lymph nodes. J Med Virol 2000; 61: 65-9.
18. Orita M, Iwahana H, Kanazagua H, Hayashi K. Detection of polymorphism of human DNA by Gel Electrophoresis as single strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70.
19. Lizano M, Berumen J, Guido MC, Casas L, García-Carrancá A. Association between Papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst 1997; 89: 1227-31.
20. Distéfano A, Picconi MA, Alonio LV, et al. Persistence of human papillomavirus in cervical lesions after treatment with diathermic large loop excision. Infec Dis Obst Gynecol 1998; 6: 214-9.
21. Howley P. Papillomaviridae and their replication. The viruses and their replication. Howley, P. En Fields Virology, tercera edición. Editado por B. Fields, D. Knip, P. Howley. Editorial Lippincott-Raven Publishers, Philadelphia. 1996 p 2045-70.
22. Levine A, Momand J, Finlay C. The p53 tumour suppressor gene. Nature 1991; 351: 453-6.
23. Hope Seyler F, Butz K. Molecular mechanism of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins. J Mol Med 1995; 73: 529-38.
24. Thomas J, Laimins L, Ruesch M. Perturbation of cell cycle control by E6 and E7 oncoproteins of human papillomaviruses. Papillomavirus Rep 1998; 9: 59-63.
25. Villa L. Human Papillomaviruses and Cervical Cancer. Adv Cancer Res 1997; 65: 321-41.
26. Bosch FX, Manos M, Muñoz N, et al. & IBSCC Study Group. Prevalence of human Papillomavirus in cervical cancer: a worldwide perspective. J Nat Cancer Inst 1995; 87: 796-802.
27. Satoh T, Nakafuku M, Kaziro Y. Function of Ras as molecular switch in signal transduction. J Biol Chem 1992; 267: 24149-52.
28. Susuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutation lung cancers by single strand conformation polymorphism analysis of polymerase chain reactions products. Oncogene 1990; 5: 1037-43.
29. Storey A, Pim D, Murray A, et al. Comparison of the in vitro transforming activities of human papillomavirus types. EMBO 1988; J. 7: 1815-20.
30. Medina-Martínez O, Vallejo J, Guido MC, Garcia Carrancá A. Ha-ras oncogene induced transcription of human papillomavirus type 18 E6 and E7 oncogenes. Mol Carcinog 1997; 19: 83-90.
31. Gaidano G, Ballerini P, Gong J, et al. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413-7.
32. Wright D, Manos MM. Sample preparation from paraffin-embedded tissues. Innis M. (ed.) PCR protocols. A guide to methods and applications. Editorial San Diego Academic Press, Inc. Harcourt Brace Jovanovich. 1990, pags 153-8.
33. Saiki RK, Bugawan TL, Hom GT, Mulis KB, Erlich HA. Analysis of enzimatically amplified beta-globin HLA-DQalfa DNA with alleles-specific oligonucleotide probes. Nature (Lond) 1986; 324: 163-6.
34. Tonon S, Picconi MA, Zinovich JB, et al. Human Papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma. S.A. Infect Dis Obst Gynecol 1999; 7: 237-43.
35. Wallboomers JMM, Jacobs MV, Manos MM, et al. Human Papillomavirus is necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
36. Cho K, Vogestein B, Genetic alterations in adenocarcinoma sequence. Cancer 1992; 76: 1927-31.
37. Denko NC, Giaccia AJ, Stringer JR, Stambrook PJ. The human Ha-ras oncogene induce geneomic instability in murine fibroblast within one cell cycle. J Acad Natl Sci USA 1994; 91: 5124-8.
38. Levi JE, Rahal P, Sarkis SA, Villa LL. Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer 1998; 76: 779-83.
39. Munirajan A, Kaman K, Bhuvahamurthy V, et al. The status of human Papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of the uterine cervix from India. Gynecol Oncol 1998; 69: 205-9.
40. Wrede D, Tidy J, Crook T, Lane D, Wousden KH. Expression of Rb and p53 proteins in HPV positive and HPV negative cervical carcinoma cell lines. Mol Carcinogen 1991; 4: 171-5.
41. Tsuda H, Hiroshashis. Frequent ocurrence of p53 gene mutation at advanced clinical stage and with aggresive histological phenotypes. Jpn J Cancer Res 1992; 83: 1184-91.
42. Chen C-A, Chen T-M, Wu C-C, Chang C-F, Hsieh C-Y. Human papillomavirus DNA and p53 status in stage bulky cervical cancer. J Cancer Res Clin Oncol 1994; 120: 678-82.
43. Nakagawa S, Yoshikawa H, Jimbo H, et al. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillo-mavirus types and 053 mutations. Br J Cancer 1999; 79: 1139-44.